Serina Therapeutics, Inc.
SER
$3.81
-$0.09-2.31%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 130.00K | -- | -14.00K | 14.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 130.00K | -- | -14.00K | 14.00K |
| Cost of Revenue | 3.65M | 3.15M | 2.95M | 2.37M | 2.42M |
| Gross Profit | -3.65M | -3.02M | -2.95M | -2.38M | -2.40M |
| SG&A Expenses | 2.74M | 2.54M | 2.91M | 1.69M | 2.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.39M | 5.70M | 5.86M | 4.06M | 5.33M |
| Operating Income | -6.39M | -5.57M | -5.86M | -4.07M | -5.31M |
| Income Before Tax | -4.60M | -6.46M | -4.82M | -2.75M | 1.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.60M | -6.46M | -4.82M | -2.75M | 1.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.00K | 14.00K | 9.00K | 12.00K | 27.00K |
| Net Income | -4.59M | -6.45M | -4.81M | -2.74M | 1.41M |
| EBIT | -6.39M | -5.57M | -5.86M | -4.07M | -5.31M |
| EBITDA | -6.38M | -5.55M | -5.84M | -4.02M | -5.26M |
| EPS Basic | -0.45 | -0.66 | -0.49 | -0.59 | 0.16 |
| Normalized Basic EPS | -0.28 | -0.40 | -0.31 | -0.17 | 0.10 |
| EPS Diluted | -0.45 | -0.66 | -0.49 | -0.30 | 0.13 |
| Normalized Diluted EPS | -0.28 | -0.40 | -0.31 | -0.17 | 0.08 |
| Average Basic Shares Outstanding | 10.34M | 10.00M | 9.76M | 18.54M | 8.85M |
| Average Diluted Shares Outstanding | 10.34M | 10.00M | 9.76M | 18.54M | 10.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |